
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
RETRACTION article
Front. Oncol. , 05 December 2023
Sec. Gastrointestinal Cancers
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1298859
This article is part of the Research Topic Novel Molecular Targets and Treatments for Gastroesophageal Cancer View all 26 articles
This article is a retraction of:
RETRACTED: Long Noncoding RNA LOC400043 (LINC02381) Inhibits Gastric Cancer Progression Through Regulating Wnt Signaling Pathway
A Retraction of the Original Research Article
Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway
By Jafarzadeh M and Soltani BM (2020) Front. Oncol. 10:562253. doi: 10.3389/fonc.2020.562253
The journal retracts the October 23, 2020, article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication concerns were identified in Figure 6B.
The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
The authors and their institution have remained unresponsive to multiple requests for the raw data for this study. Given extant concerns over the validity of the study, the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers.
The authors disagreed with this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway. Front. Oncol. 13:1298859. doi: 10.3389/fonc.2023.1298859
Received: 22 September 2023; Accepted: 27 September 2023;
Published: 05 December 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.